465 related articles for article (PubMed ID: 34771511)
1. Do Lipid-based Nanoparticles Hold Promise for Advancing the Clinical Translation of Anticancer Alkaloids?
Loh JS; Tan LKS; Lee WL; Ming LC; How CW; Foo JB; Kifli N; Goh BH; Ong YS
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771511
[TBL] [Abstract][Full Text] [Related]
2. Micro-syringe chip-guided intratumoral administration of lipid nanoparticles for targeted anticancer therapy.
Kim J; Song S; Gwak M; Cho H; Yun WS; Hwang N; Kim J; Lee JS; Kim DH; Kim H; Jeon SI; Kim TI; Kim K
Biomater Res; 2023 Oct; 27(1):102. PubMed ID: 37845762
[TBL] [Abstract][Full Text] [Related]
3. Drug Delivery of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) to Target Brain Tumors.
Mehrdadi S
Adv Pharm Bull; 2023 Jul; 13(3):512-520. PubMed ID: 37646057
[TBL] [Abstract][Full Text] [Related]
4. Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion.
Huang ZR; Hua SC; Yang YL; Fang JY
Acta Pharmacol Sin; 2008 Sep; 29(9):1094-102. PubMed ID: 18718178
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles.
Wong HL; Bendayan R; Rauth AM; Li Y; Wu XY
Adv Drug Deliv Rev; 2007 Jul; 59(6):491-504. PubMed ID: 17532091
[TBL] [Abstract][Full Text] [Related]
6. Navigating the Nose-to-Brain Route: A Systematic Review on Lipid-Based Nanocarriers for Central Nervous System Disorders.
Agosti E; Zeppieri M; Antonietti S; Battaglia L; Ius T; Gagliano C; Fontanella MM; Panciani PP
Pharmaceutics; 2024 Feb; 16(3):. PubMed ID: 38543223
[TBL] [Abstract][Full Text] [Related]
7. Solid lipid nanoparticles: a modern formulation approach in drug delivery system.
Mukherjee S; Ray S; Thakur RS
Indian J Pharm Sci; 2009 Jul; 71(4):349-58. PubMed ID: 20502539
[TBL] [Abstract][Full Text] [Related]
8. Lipid-based Nanoparticles for the Targeted Delivery of Anticancer Drugs: A Review.
Khodaverdi H; Zeini MS; Moghaddam MM; Vazifedust S; Akbariqomi M; Tebyaniyan H
Curr Drug Deliv; 2022; 19(10):1012-1033. PubMed ID: 35078396
[TBL] [Abstract][Full Text] [Related]
9. Potential of Lipid Nanoparticles (SLNs and NLCs) in Enhancing Oral Bioavailability of Drugs with Poor Intestinal Permeability.
Talegaonkar S; Bhattacharyya A
AAPS PharmSciTech; 2019 Feb; 20(3):121. PubMed ID: 30805893
[TBL] [Abstract][Full Text] [Related]
10. Lipid Nanoparticles Functionalized with Antibodies for Anticancer Drug Therapy.
Marques AC; Costa PC; Velho S; Amaral MH
Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678845
[TBL] [Abstract][Full Text] [Related]
11. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
12. Fabrication and Assessment of Diosgenin Encapsulated Stearic Acid Solid Lipid Nanoparticles for Its Anticancer and Antidepressant Effects Using
Khan H; Nazir S; Farooq RK; Khan IN; Javed A
Front Neurosci; 2021; 15():806713. PubMed ID: 35221890
[TBL] [Abstract][Full Text] [Related]
13. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
[TBL] [Abstract][Full Text] [Related]
14. A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells.
Shuhendler AJ; Cheung RY; Manias J; Connor A; Rauth AM; Wu XY
Breast Cancer Res Treat; 2010 Jan; 119(2):255-69. PubMed ID: 19221875
[TBL] [Abstract][Full Text] [Related]
15. Lipid Nanoparticles as a Promising Drug Delivery Carrier for Topical Ocular Therapy-An Overview on Recent Advances.
Jacob S; Nair AB; Shah J; Gupta S; Boddu SHS; Sreeharsha N; Joseph A; Shinu P; Morsy MA
Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335909
[TBL] [Abstract][Full Text] [Related]
16. Lipid nanoparticles for chemotherapeutic applications: strategies to improve anticancer efficacy.
Lin X; Gao R; Zhang Y; Qi N; Zhang Y; Zhang K; He H; Tang X
Expert Opin Drug Deliv; 2012 Jul; 9(7):767-81. PubMed ID: 22554018
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of anticancer efficacy using modified lipophilic nanoparticle drug encapsulation.
Lee P; Zhang R; Li V; Liu X; Sun RW; Che CM; Wong KK
Int J Nanomedicine; 2012; 7():731-7. PubMed ID: 22359452
[TBL] [Abstract][Full Text] [Related]
18. Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.
Yingchoncharoen P; Kalinowski DS; Richardson DR
Pharmacol Rev; 2016 Jul; 68(3):701-87. PubMed ID: 27363439
[TBL] [Abstract][Full Text] [Related]
19. Parenteral Lipid-Based Nanoparticles for CNS Disorders: Integrating Various Facets of Preclinical Evaluation towards More Effective Clinical Translation.
Ilić T; Đoković JB; Nikolić I; Mitrović JR; Pantelić I; Savić SD; Savić MM
Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839768
[TBL] [Abstract][Full Text] [Related]
20. Quercetin and piperine enriched nanostructured lipid carriers (NLCs) to improve apoptosis in oral squamous cellular carcinoma (FaDu cells) with improved biodistribution profile.
Chaudhari VS; Gawali B; Saha P; Naidu VGM; Murty US; Banerjee S
Eur J Pharmacol; 2021 Oct; 909():174400. PubMed ID: 34332920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
